Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malaria.
Main Authors: | Steffen Borrmann, Tim Peto, Robert W Snow, Win Gutteridge, Nicholas J White |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2008-11-01
|
Series: | PLoS Medicine |
Online Access: | http://europepmc.org/articles/PMC2586344?pdf=render |
Similar Items
-
Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malaria.
by: Borrmann, S, et al.
Published: (2008) -
Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malaria
by: Borrmann, S, et al.
Published: (2008) -
Optimising statistical methodologies for estimating antimalarial efficacy for uncomplicated Plasmodium falciparum malaria
by: Dahal, P
Published: (2018) -
Some considerations in the design and interpretation of antimalarial drug trials in uncomplicated falciparum malaria
by: Stepniewska Kasia, et al.
Published: (2006-12-01) -
Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated <it>Plasmodium falciparum </it>malaria in Senegal
by: Faye Oumar, et al.
Published: (2007-06-01)